12:00 AM
 | 
Jan 02, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Synergy Ablation System regulatory update

FDA approved a PMA for AtriCure's Synergy Ablation System to treat atrial fibrillation (AF) during open-heart concomitant coronary artery bypass grafting and/or valve replacement or repair procedures. AtriCure is required...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >